SIA
NKGNW

Schechter Investment Advisors’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Schechter Investment Advisors’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,279
Closed -$2.14K – 686
2023
Q2 		$2.14K Hold
11,279
– – ﹤0.01% 659
2023
Q1 		$1.58K Hold
11,279
– – ﹤0.01% 692
2022
Q4 		$958 Buy
+11,279
New +$947 ﹤0.01% 850

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Schechter Investment Advisors's NKGNW Position: Q3 2023 in Review

Schechter Investment Advisors sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2023, closing a stake of 11,279 shares — an estimated $2.14K sold.

Schechter Investment Advisors first reported a position in NKGNW in Q4 2022 and held it in 3 quarters. The position peaked at $2.14K in Q2 2023. 21 funds tracked by Wall St. Rank hold NKGNW as of Q3 2023.

  • Schechter Investment Advisors reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2023 after selling out during the quarter.
  • Schechter Investment Advisors sold 11,279 NKGen Biotech, Inc. Warrants shares in Q3 2023, an estimated $2.14K.
  • Schechter Investment Advisors first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 3 quarters.
  • Schechter Investment Advisors's NKGen Biotech, Inc. Warrants position peaked at $2.14K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2023.

Based on Schechter Investment Advisors's 13F filing for Q3 2023, filed 6 Nov 2023.